chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse effects were reported; expired dose of MMR-II that was administered to an adult patient; expired dose of MMR-II that was administered to an adult patient; This spontaneous report was received from a nurse and refers to an adult patient of unknown gender and age.The patient's pertinent medical history, concomitant medications, concurrent conditions and drug reactions/allergies were not reported.  On 12-SEP-2023, the adult patient was vaccinated with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) Subcutaneous Injection, first dose given subcutaneously, lot number: W011885 and expiration date was reported as 04-SEP-2023, (dose, strength and anatomical location were not provided) as prophylaxis (product administered to patient of inappropriate age and expired product administered). No additional adverse events (AEs) reported and no adverse effects were reported.
Patient had some throat tightness and explained it as he thought "his veins were on fire".
First vaccine given at 3 weeks pregnant. Low progestrone through entire first trimester. Baby was growing on par with due date. No genetic abnormalities seen at 12 week NIPT scan. Second vaccine administered at 16 weeks and 2 days. At 20 week anatomy scan, it was noted that growth of baby slowed/stalled at the time of the second vaccine. Grew slow, 2 weeks behind expected growth following second vaccine. Lost the baby to stillbirth at 22 weeks.  Bloodwork during pregnancy showed no risk of infection. Genetic testing came back normal 46 xy. No infections or issues with placenta.
This is a literature case, initially received on 04-Jun-2018 and concerns a female patient of unspecified age. On an unspecified date, the patient was administered with INN Flu Vaccine Seasonal (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On an unspecified date, (reported as following recent influenza vaccination), the patient experienced ascending weakness. On an unspecified date, the patient was hospitalized and was treated for suspected acute inflammatory demyelinating polyradiculoneuropathy (AIDP). Over the course of hospitalization, the patient experienced a progressive loss of vision which led to cortical blindness. During hospitalization, results of magnetic resonance imaging (MRI) were typical for posterior reversible encephalopathy syndrome (PRES), including scattered areas of cortical and subcortical T2 and T2 Flair hyperintensities within the occipital and parietal lobes. On an unspecified date, the patient's vision improved, but she experienced hallucinations including people changes in appearances, as well as objects around the room changing in size. At the time of this report, the outcome of the events was not reported. The reporter assessed the events as serious due to hospitalization. The reporter assessed the events as related to the suspect vaccine.
Immediately following the injections, I felt very sick to my stomach and headache, stomach aches/cramps and diarrhea. Same was with the "little white tablets" dont know the name. (pyrogistbromide??) that we took, I do not remember the name of the other vaccine I received, 1 was anthrax vacc. Discharge Summary received on 2/14/2005 states hemiplegia. Medical records received on 2/14/2005 states CVA, pancreatitis, dysphagia, weight loss, melena and fever. Medical Record received on 2/18/2005 states TIA.
PT HAS BEEN ON DPXT FOR ABOUT 4 YEARS FOR ECZEMA & HAS CONTROLLED HER SX WELL. SHE RECEIVED J&J COVID VACCINE ON SATURDAY & HAD DOSE OF DPXT ON SUNDAY & IS HAVING BREAKTHRU IN ECZEMA SX NOW. PT STATES AFTER GETTING J&J VACCINE ON SATURDAY, SHE HAD NO FEVER, FELT LITTLE TIRED IN AFTERNOON, MAYBE SOME CHILLS (BUT WEATHER WAS COLD), & NOTHING ELSE TO NOTE OF. SUNDAY WAS HER DPXT DOSE. SHE TOOK IT IN THE AM & ABOUT 5 HOURS LATER SHE STARTED TO HAVE BREAKTHRU IN SX. HER MOST SEVERE TROUBLE SPOTS PRE-DPXT TX WAS AROUND HER EYES, CHEEKS, FACE AREA. SHE STARTED TO FEEL INFLAMMATION AROUND EYES & UPPER CHEEEKS ON SUNDAY. THIS MORNING THE SX FELT VERY STRONG BUT SEEM TO BE DIMINISHING SOMEWHAT THROUGHOUT THE DAY. SHE IS HOPING THAT IT WILL CONTINUE TO IMPROVE & RESOLVE TOMORROW. SHE CAN FEEL THE INFLAMMATION UNDER THE SKIN - NO VISUAL SX YET. SHE FEELS LIKE THE COVID VACCINE SOMEHOW BLOCKED THE EFFECTS OF HER DPXT. PT HAS NEVER HAD THESE SX DURING HER TX OF DPXT. THE DPXT HAS CONTROLLED ALL HER SX WELL THROUGH THE PAST FEW YEARS. SHE WANTED TO INFORM US SO THAT WE CAN COLLECT DATA. ADV PT THAT IF SX DO NOT RESOLVE OR IF THEY GET WORSE, CONTACT MD FOR ADV. PT AGREED.
p/vax pt exp h/a;h/a have cont since first vax, have not changed in frequency & or intensity; Per follow-up: Since first vaccine, 20 Oct 98, patient experienced headaches. Headaches have continued since first vaccine, have not changed in frequency and or intensity.
My daughter suffered a Grand mal seizure early in the morning about 6 AM. It was discovered by her Aunt and cousin and it lasted about 5 minutes. She had convulsions, her eyes were rolled back, she was unresponsive, and she lost her bodily functions. She was taken by ambulance to the hospital where they conducted tests. This was her first-ever seizure and her father and mother do not suffer from them. Her grandmother (father's side) suffered from them when she was younger a few times. It may not have any correlation to the vaccine, but I (mother) thought it should be reported. We are currently following up with a neurologist.
Rapid heart beat which went upto 165bpm; Raised blood pressure upto 149/89; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Rapid heart beat which went upto 165bpm) and HYPERTENSION (Raised blood pressure upto 149/89) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PALPITATIONS (Rapid heart beat which went upto 165bpm) and HYPERTENSION (Raised blood pressure upto 149/89). At the time of the report, PALPITATIONS (Rapid heart beat which went upto 165bpm) and HYPERTENSION (Raised blood pressure upto 149/89) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 148/89 (High) 148/89. On an unknown date, Heart rate: 165 (High) 165 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product details was not reported.  Treatment details was not reported .   Reporter did not allow further contact
Feeling very run down; Large red bump on her arm at injection site; Large red bump on her arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Feeling very run down), VACCINATION SITE MASS (Large red bump on her arm at injection site) and VACCINATION SITE ERYTHEMA (Large red bump on her arm at injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TREPROSTINIL SODIUM (TYVASO) for Pulmonary arterial hypertension.    Concurrent medical conditions included Pulmonary arterial hypertension (Primary pulmonary arterial hypertension). Concomitant products included TADALAFIL and MACITENTAN (OPSUMIT) for an unknown indication.   On 13-Oct-2020, the patient started TREPROSTINIL SODIUM (TYVASO) (unknown route) at an unspecified dose four times per day. On 13-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2022, the patient experienced FATIGUE (Feeling very run down), VACCINATION SITE MASS (Large red bump on her arm at injection site) and VACCINATION SITE ERYTHEMA (Large red bump on her arm at injection site). At the time of the report, FATIGUE (Feeling very run down), VACCINATION SITE MASS (Large red bump on her arm at injection site) and VACCINATION SITE ERYTHEMA (Large red bump on her arm at injection site) outcome was unknown.      No treatment medication information provided.   This case was linked to MOD-2021-102229 (Patient Link).
Got cold. Then had a cramp at right ankle. Then body temperature dropped. Skin got very cold then I stopped breathing and fainted. Was given CPR by husband.
08/26, 08/27, 08/28/2005 developed red, itchy rash on neck, legs, trunk. 08/27 nausea, anorexia. 08/31 developed fever (99.9 - 100), back and body aches. Mouth sores developed. Neck glands hurting, right side with small bump. Swelling in right neck has gone down. 09/05/2005 fever returns (low grade) and headache.
Hospitalized on 8/29/2021 with COVID19+, viral pneumonia and leukocytosis.
This spontaneous report was received from a pharmacist and refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On an unknown date, the patients were vaccinated with improperly stored (Merck) VARIVAX (lot # K008821, expiration date: 19-JUN-2016; dose, indication and route of administration were not reported). Concomitant therapy was not provided. No symptoms were reported. This is one of several reports received from the same reporter. Additional information is not expected, as there was no consent to contact the reporter.
When he caught COVID-19 he started feeling really achy and tired He had a sore throat and was warm but had no fever. He was sneezing and coughing. He had pain in his lower back and a headache. On June 22, 2022 he was feeling worse. His blood pressure was fine, but then all of a sudden he felt like he was having a hard time taking in air. His pulse was around 92 beats per minute. He was having pain in his right leg as well. We called his physician. The advice nurse called us back and said that he should go to the ER. He had pain in his sternum as well and the nurse thought it could have something to do with his heart. When we went to the ER the physician checked him out. They gave him Remdesivir. He was admitted and stayed at the hospital. They ended up giving him 3 doses of the Remdesivir, an albuterol inhaler, and cough medicine. He continued taking his vitamins. He was hospitalized for 2 nights and 3 days. His symptoms are not present anymore.
This spontaneous report as received from a 64 year old male patient. Patient's drug reactions and allergies including: patient had received an unspecified FLU vaccine: influenza virus vaccine (manufacturer unknown) (strength, formulation, lot #, dose, route and duration were unspecified) in 1993, and 2 days after receiving this unspecified flu vaccine he then developed the flu (MARRS# 1310USA012808); On 03-SEP-2013, patient received an unspecified pneumonia shot: pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (strength, formulation, lot #, dose, route and duration were unspecified) as well as an unspecified tetanus shot: Tetanus and Diptheria Toxoids, Adsorbed (manufacturer unknown) (strength, formulation, lot #, dose, route and duration were unspecified) and then developed pain (unspecified date in 2013) which he recovered from 2 days later. The action taken was unknown. Patient had liquid MORPHINIE (unspecified manufacturer/dose/frequency) and made his "arm completely red" and raised his blood pressure (date unspecified). On unspecified date, patient had a hernia surgery. On 17-OCT-2013 the patient was vaccinated with ZOSTAVAX (vial, "one shot", route as "under the skin", lot #, strength, formulation were unknown) for prevention of shingles. After receiving ZOSTAVAX, on 18-OCT-2013, patient developed an injection site reaction which included redness, swelling, itching, warmth, pain, and the reaction site is the size of a silver dollar that was red and raised (MARRS# 1310USA011487). Additional information is not expected.
Pain and rash/heat at injection site. Aching Joints, Low fever, Nausea, Double vision. 24 hours after shot, better by 48 hours.
Tremors/Shakes 20 minutes following vaccine lasting 2 hours. Experienced tremors for 10-15 minutes the next day along with some chest discomfort with BP 134/84. He tried to self report but was unable.
Started having body aches, hoarseness, wheezing, and hard time breathing, alot of cold symptoms
Redness described right arm injection site.  Redness size of silver dollar.  ON Sat. 12/13/03, by 14:00, had spread from upper right arm to neck that progressed down arm to chest wall and around breast.  Redness site including under her right arm were very painful.  No swelling, no itching, no shortness of breath or tightness in throat.  Also felt nauseated.  Recommends pt be seen by HCP.  Seen in ER 12/13/03 17:30 by MD.  Diagnosed as drug reaction.  MD also stated she probably had pneumonia before.  Prescribed Benadryl.  Took Benadryl and felt very sleepy.  By Sunday 12/14/03, redness had began to fade and pallor was decreasing.  Feeling much better today.  Continued fading of redness and pain.  Advised to call MD and inform of reaction.
In late October, I felt some warmth in my left breast. It also appeared larger. I wasn't in any pain, and I had a mammogram coming up on 10/27/2022. They said that they saw some calcification that didn't look normal, so they wanted me to come back for a diagnostic mammogram on 11/16/2022. The result of that was that something abnormal was going on and they wanted to follow up with a biopsy on 12/06/2022. I found out later that day that I had a condition called DCIS in stage zero. I met with a surgeon on 12/23/2022. I was told I could do a lumpectomy or mastectomy. I elected the lumpectomy and had that on 01/19/2023. I had to have a second surgery on 02/07/2023 because one of the margins did not come clean. I am now receiving radiation treatment. Today was day 7 of 20.
Had the cold sweats all night and did not sleep. For the next couple days my kidneys hurt like I was dehydrated. I drank water but this didn't really help. Every few days since then I get little kidney pains/cramps like I was dehydrated. These are minor and short-lived, but concerning that it has not gone away a month after I got the vaccine.
Localized swelling at injection area a couple of days afterwards and continued pain in the entire arm up to 2 weeks after second dose.  Left arm felt as if there was a torn muscle and 10 days after second dose, a large bruise appeared running lengthwise from armpit to below the interior elbow.  the torn muscle feeling is subsiding though and seems to be getting better day by day.
Information has been received from a certified medical assistant referring to multiple unspecified patients of unknown age and gender. The patients concurrent conditions and medical history were not reported. On an unknown date the patients were vaccinated with doses of improperly stored GARDASIL 9 (lot # L019297 with expiration date 18-AUG-2017, dose, frequency and route were unknown). The patient's concomitant medication was not reported. No adverse effects reported. This is one of two reports received from the same reporter. Additional information has been requested.
The vaccine was mixed with a sterile water diluent instead of the diluent provided with the vaccine.
No adverse event; Patient received 1st booster dose of the Moderna Covid 19 vaccine after its expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received 1st booster dose of the Moderna Covid 19 vaccine after its expiration date) and NO ADVERSE EVENT (No adverse event) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045L21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received 1st booster dose of the Moderna Covid 19 vaccine after its expiration date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received 1st booster dose of the Moderna Covid 19 vaccine after its expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received 1st booster dose of the Moderna Covid 19 vaccine after its expiration date).    No concomitant medication was reported.  Date the vial was initially stored in the refrigerator: 19-Jul-2022.  On 19-Jul-2022, the patient received the first booster dose.  The vial did not undergo any temperature excursions.  No treatment information was reported.
Systemic: Fainting / Unresponsive-Mild, Additional Details: Pt had a vasovagal episode 3 minutes after vaccination given. Pt assisted to the floor. Vital signs  100/74, pulse 93, 99% room air. This was her first ever vaccination per mother. She was assisted back to clinic room. Blood sugar 84. Mother states pt had been fasting. Mother allowed pt to stay 10 more minutes but refused a blood pressure recheck. Mother states she has to go because she has another appointment but will give her fruits. Mother instructed to go to call emergency if fainting reoccurs
Pain at site of injection started 2 days after shot and progressively Sharp pain when lifting or reaching for items. It still painful at site of injection and slight swelling of tendon.
felt a little under the weather; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (felt a little under the weather) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 032M20A) for COVID-19 vaccination.     The patient's past medical history included Lupus erythematosus (Has had lupus for about 13 years). Concurrent medical conditions included Mixed connective tissue disease (Has had for about 13 years). Concomitant products included HYDROXYCHLOROQUINE and PREDNISONE (RAYOS) for Lupus erythematosus and Mixed connective tissue disease.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (felt a little under the weather). At the time of the report, VACCINATION COMPLICATION (felt a little under the weather) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided by the reporter.
This spontaneous case, initially received from other non-health professional (consumer) on 26-Oct-2018, concerns a 41-year-old, adult, female patient. On 16-Oct-2018, the vaccine underwent temperature excursion. On an unspecified date in Oct-2018, the patient was inadvertently administered FLUCELVAX QIVc that underwent temperature excursion [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252664 and expiry date: 30-Jun-2019]. The patient did not experience any adverse events after vaccination. The reporter assessed this case as non-serious. This case (201805017) was cross-linked to the case: 201805002 reported by the same reporter. Follow-up report received from the reporter on 13-Nov-2018: The onset date of the event incorrect product storage was updated as 16-Oct-2018 and expiry date of the suspect vaccine was updated as 30-Jun-2019. The reporter confirmed that, the patient did not experience any adverse events after vaccination. The reporter refused to provide the patient's initials and date of vaccine administration. The narrative and case comment were amended accordingly.
Initial unsolicited report received from nurse on 17-May-2017. This case involves a female patient (age not reported) who was vaccinated with unknown dose of ADACEL batch number- U5542AA in left arm and MENACTRA batch number- U5567CA arm right (expiration date, dose in series, route were not reported) on an unspecified date. Patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patients had left arm was swollen with a knot and fatigue in arm when lifting and reaction got worse in both arms. It was also a case of actual medication error due to inappropriate age at vaccine administration. Laboratory examinations were not reported. Corrective treatment were not reported. The outcome of event was not reported. List of documents held by sender: none.
Patient reported that on 10/7/2023 she noticed that her right eye was red and bleeding inside. She went to the fire department because she stated they are first responders but was told that she should follow up with her ophthalmologist. She stated that she will call when the office opens
Grand mal seizure 3 weeks after vaccine. I now have Grand Mal seizures about every 2-3 months. Treatment so far is anti-seizure meds. No genetic  or family history.
she has high cholesterol; she also has a high BMI; This is a spontaneous report from a contactable consumer. A 60-year-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot number was not reported), dose 1 via an un-specified route of administration on 26Feb2021 as dose 1, single for covid-19 immunisation (at the age of 60-year-old). The patient medical history and concomitant medications were not reported. The patient took her first dose on 26Feb2021. She is concerned about having to change her facility for her next dose of vaccine because as she mentioned, she has high cholesterol, she also has a high BMI and she is 60 years old. Her next dose will be given on 19Mar2021. The patient underwent lab tests and procedures which included blood cholesterol: high on an unspecified date, body mass index: high on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.